Results 151 to 160 of about 59,596 (250)

Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial. [PDF]

open access: yesInflamm Bowel Dis
Afzali A   +17 more
europepmc   +1 more source

Achieving Minimal-to-No Pain in Women with Endometriosis Treated with Relugolix Combination Therapy: SPIRIT Extension Trial. [PDF]

open access: yesInt J Womens Health
Lukes AS   +8 more
europepmc   +1 more source

Further data to address the Alzheimer's coverage with evidence development questions. [PDF]

open access: yesAlzheimers Dement
Boustani M   +9 more
europepmc   +1 more source

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Pittock SJ   +14 more
europepmc   +1 more source

Biomedical sensing analyzer (BSA) for mobile-health (mHealth)-LTE

open access: yes, 2014
The rapid expansion of mobile-based systems, the capabilities of smartphone devices, as well as the radio access and cellular network technologies are the wind beneath the wing of mobile health (mHealth).
Sasan Adibi (11629147)
core  

LTE ?????? ?????? ???????????? ????????? ??? ????????? ????????? ?????? ???????????? ?????? ?????????

open access: yes, 2015
??? ???????????? ?????? ??? ????????? ?????? ???????????? ?????? ????????? ???????????? ?????? ???????????? ?????? ?????????(NFV; Network Functions Virtualization) ????????? LTE(Long Term Evolution) ?????? ?????? ???????????? ????????? ?????? ????????????
?????????
core  

Protective effect of <i>Loranthus tanakae</i> Franch. & Sav. on allergic asthma induced by ovalbumin. [PDF]

open access: yesVet Med (Praha)
Park SH   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy